top of page
NeathAquaduct.jpg

What are we currently working on?

Search

Prepared by Dr Nimish Shah January 2026


Overview

The LMC have received reports of increasing pressure on GPs to sign prescriptions for remote clinicians—including non-GP specialists—within the Out of Hours (OOH) service. The feedback the LMC have received suggests that the current "Crown Indemnity" assurance may be creating a false sense of security. While it provides financial cover for the Health Board, it does not mitigate the personal professional risk to a GP's registration when signing for a clinical assessment they did not perform.


This briefing note covers:

  • The distinction between Financial Indemnity and Professional Défense

  • The specific risks of signing for non-GP specialists (e.g., Paediatricians)

  • The contractual obligations and the role of the LNC in negotiating these terms


1. The Core Risk: Responsibility vs. Cover


There is a significant distinction between financial protection and professional protection. It is vital that clinicians understand the limits of Health Board cover:

  • Financial Indemnity (Health Board/Crown Indemnity): This covers the financial cost of a clinical negligence claim (payouts to patients). It does not provide personal legal representation.

  • Professional Protection (MDOs e.g., MPS, MDU): This provides legal defense for GMC investigations, Coroner’s Inquests, and Disciplinary hearings.


Key takeaway: A GP who signs a prescription based on a remote assessment they did not perform inherits the legal responsibility for that prescription. If the assessment is later found to be flawed, the "signer" remains accountable to the GMC.


2. Specialist-to-GP Prescribing (Paediatrics)


The recent request for GPs and Pharmacists to sign for remote Paediatricians carries a heightened professional risk:

  • Scope of Practice: GPs are frequently asked to sign for dosages or medications (e.g., weight-based calculations or off-license uses) that sit outside standard primary care guidelines.

  • GMC Guidance: Good practice in prescribing (2021) states that you must only prescribe if you have sufficient knowledge of the patient’s health and are satisfied that the medication is clinically justified.


3. Contractual & Negotiation Routes


Responsibility is often dictated by the "fine print" of employment:

  • Individual Contracts: GPs must verify if "remote cross-signing" is a specified duty in their signed OOH contract. If it is a contractual requirement, the GP is obliged to perform it, provided it is clinically safe.

  • Local Negotiating Committee (LNC) Role: While the LMC represents the profession broadly, the LNC is the formal body responsible for negotiating terms for those on Health Board contracts. Collective disputes regarding these working conditions should be escalated through the LNC.


4. Recommendations for GPs


  • Seek Individual Advice: Every GP should contact their Medical Defence Organisation (MDO) for a written opinion regarding their specific OOH role and the "line of sight" required for safe signing.

  • Document Concerns: If signing under protest or due to contractual obligation, ensure the rationale and the remote clinician's details are clearly logged.

  • Competence First: If a prescription feels clinically unsafe or is outside your competence, you have a professional right (and duty) to decline and suggest an alternative pathway.

 
 
 

Regarding provision of home visits for flu vaccinations and the recent direction of patients from the immunisation team.


We understand the significant capacity pressures the practice is currently facing, particularly when managing "opportunistic" vaccination alongside routine care. However, we have reviewed the 2025-26 PCCS:I Service Specification, and we must clarify the practice's obligations to ensure you remain compliant with the contract you have signed.


Contractual Requirements and Equality

Under the service specification for Immunisations and Vaccinations, the practice is responsible for delivering the service to its eligible registered population. Specifically, regarding accessibility, the specification (page 25, sections s–u) states:

  • Accessibility: Services must be accessible, appropriate, and sensitive to the needs of all persons.

  • Equality Act 2010: Eligible persons must not experience "particular difficulty" in accessing the service due to protected characteristics, specifically disability.

  • Home Visiting: If a patient has a disability or clinical condition that prevents them from attending the surgery, the practice is required to provide a reasonable adjustment to ensure they are not excluded. In this context, that adjustment may be a home visit.


Determining Eligibility for Home Visits

While the immunisation team may be directing patients to you, the practice retains the clinical responsibility to determine if a home visit is strictly necessary.

A home visit should be reserved for those who are truly housebound due to illness or disability. If a patient is physically able to attend the surgery (or does so for other appointments), the practice is within its rights to insist they attend a clinic. However, if a disability truly prevents them from attending, the PCCS:I framework requires the practice to facilitate the vaccination at their place of residence.

You could as per section (u) of the specification, if capacity makes this impossible, you should engage with the Local Health Board to discuss how they can support your equality plan for under-served or housebound groups.

Failure to provide these visits for eligible disabled patients could be viewed as a breach of both the PCCS:I specification and the Equality Act 2010.

We hope this clarifies the guidance but ultimately it is up to the practice that they do not discriminate against a patient who has a true disability that prevents them from leaving their house.


Your practice may wish to take this into consideration in deciding on whether to participate in next year's influenza campaign.


 
 
 

Dr Robin Spacie, on behalf for MLMC, put in a request to the Welsh Government for information under the Freedom of Information Act (2000) regarding how much Consultant Connect has cost per year for the last 5 years and how many completed calls are made on Consultant Connect per year for the last 5 years, across Wales in total and for each health board.


The costs given are:

Year

Cost

2020-21

£453,600.00

2021-22

£693,755.00

2022-23

£742,774.20

2023-24

£792,003.00

2024-25

£758,832.80

Health board and total numbers of calls and messages from 2020- to end of financial year 2024/25 are available in Appendix A within the full document available below.



 
 
 
bottom of page